GLP-1 RAs offer a revolutionary weight loss strategy for obesity, yet the associated muscle loss raise concerns about their potential to induce sarcopenic obesity in older adults, especially following weight cycling with GLP-1 RAs. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.